Discovery of TRV130, a G protein biased agonist of the μ-opioid receptor, for the treatment of acute severe pain

被引：0
|
作者：
Crombie, Aimee [1 ]
Chen, Xiao-Tao [1 ]
Pitis, Philip [1 ]
Liu, Guodong [1 ]
Yuan, Catherine [1 ]
Gotchev, Dimitar [4 ]
Yamashita, Dennis [3 ]
Violin, Jonathan [2 ]
机构：
[1] Trevena Inc, Chem, King Of Prussia, PA USA
[2] Trevena Inc, Biol, King Of Prussia, PA USA
[3] GSK, Discovery Partnerships Acad, Boston, PA USA
[4] Teva Pharmaceut, Chem, W Chester, PA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 2015年 / 249卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
34
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Discovery of SHR9352: A Highly Potent G Protein-Biased μ-Opioid Receptor Agonist
    Li, Xin
    He, Wei
    Chen, Yang
    Yang, Guimei
    Wan, Hong
    Zhang, Lei
    Hu, Qiyue
    Feng, Jun
    Zhang, Zhigao
    He, Feng
    Bai, Chang
    Zhang, Lianshan
    You, Li
    Tao, Weikang
    ACS OMEGA, 2017, 2 (12): : 9261 - 9267
  • [22] APOLLO-1: Phase 3 Study of Oliceridine (TRV130) for Management of Acute Pain
    Gan, Tong
    Soergel, David G.
    Burt, David A.
    Skobieranda, Franck
    ANESTHESIA AND ANALGESIA, 2017, 124 : 744 - 744
  • [23] Structure Activity Relationships and Discovery of a G Protein Biased μ Opioid Receptor Ligand, [(3-Methoxythiophen-2-yl)methyl]a2[(9R)-9-(pyridin-2-y1)-6-oxaspiro-[4.5]clecan-9-yl]ethylpamine (TRV130), for the Treatment of Acute Severe Pain
    Chen, Xiao-Tao
    Pitis, Philip
    Liu, Guodong
    Yuan, Catherine
    Gotchev, Dimitar
    Cowan, Conrad L.
    Rominger, David H.
    Koblish, Michael
    DeWire, Scott M.
    Crombie, Aimee L.
    Violin, Jonathan D.
    Yamashita, Dennis S.
    JOURNAL OF MEDICINAL CHEMISTRY, 2013, 56 (20) : 8019 - 8031
  • [24] Desmetramadol Is Identified as a G-Protein Biased μ Opioid Receptor Agonist
    Zebala, John A.
    Schuler, Aaron D.
    Kahn, Stuart J.
    Maeda, Dean Y.
    FRONTIERS IN PHARMACOLOGY, 2020, 10
  • [25] TRV130, a novel biased opioid ligand, elicits increased analgesia with reduced adverse effects compared to morphine in healthy volunteers
    Soergel, D.
    Subach, R.
    James, I.
    Violin, I.
    Skobieranda, F.
    Sadler, B.
    Burnham, N.
    Theisen, T.
    Lark, M.
    Webster, L.
    JOURNAL OF PAIN, 2014, 15 (04): : S95 - S95
  • [26] A Novel G Protein-Biased Agonist at the δ Opioid Receptor with Analgesic Efficacy in Models of Chronic Pain
    Conibear, Alexandra E.
    Asghar, Junaid
    Hill, Rob
    Henderson, Graeme
    Borbely, Eva
    Tekus, Valeria
    Helyes, Zsuzsanna
    Palandri, Josephine
    Bailey, Chris
    Starke, Ingemar
    von Mentzer, Bengt
    Kendall, David
    Kelly, Eamonn
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2020, 372 (02): : 224 - 236
  • [27] Oliceridine (TRV130) Has a Differentiated Profile of G Protein and β-arrestin Signaling Versus Select Opioids
    Cowan, Conrad
    Gowen-MacDonald, William
    Graczyk, Thomas
    Lark, Mike
    PAIN MANAGEMENT NURSING, 2017, 18 (02) : 72 - 72
  • [28] TRV0109101, a G Protein-Biased Agonist of the μ-Opioid Receptor, Does Not Promote Opioid-Induced Mechanical Allodynia following Chronic Administration
    Koblish, Michael
    Carr, Richard, III
    Siuda, Edward R.
    Rominger, David H.
    Gowen-MacDonald, William
    Cowan, Conrad L.
    Crombie, Aimee L.
    Violin, Jonathan D.
    Lark, Michael W.
    JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2017, 362 (02): : 254 - 262
  • [29] Discovery of Biased Mu-Opioid Receptor Agonists for the Treatment of Pain
    Ma, Mengjun
    Li, Xiang
    Tong, Kun
    Cheng, Jingchao
    Yu, Zixing
    Ren, Fengxia
    Zhong, Bohua
    Shi, Weiguo
    CHEMMEDCHEM, 2020, 15 (01) : 155 - 161
  • [30] Can oliceridine (TRV130), an ideal novel. receptor G protein pathway selective (μ-GPS) modulator, provide analgesia without opioid-related adverse reactions?
    Ok, Hwoe Gyeong
    Kim, Su Young
    Lee, Su Jung
    Kim, Tae Kyun
    Huh, Billy K.
    Kim, Kyung Hoon
    KOREAN JOURNAL OF PAIN, 2018, 31 (02): : 73 - 79
12345